Lisa Yerke, DDS, MS, from University at Buffalo, answers our questions about her research presented during a poster session at the 2018 AIBD Meeting on the use of proton pump inhibitors for IBD and its...
In a Keynote session at the 2018 AIBD Meeting, Dr Marla Dubinsky discussed the impact of IBD on fertility and the need for a multidisciplinary approach to properly educate patients on their options.
At the 2018 AIBD Meeting, Dr Millie Long highlighted different dermatologic complications that can arise among patients with IBD and when a gastroenterologist should recommend discontinuation of treatment.
...
In a Keynote session at the 2018 AIBD Meeting, Dr Charles Bernstein highlighted environmental factors that play a role in the risk of inflammatory bowel disease.
Researchers analyzed the impact medication therapy management has on patients using injectable biologic treatments for IBD as well as on clinicians and their office staff.
Researchers sought to determine the effects of prior TNFi and/or immunosuppressant failure on the efficacy and safety of tofacitinib in patients with ulcerative colitis.
At the 2018 AIBD Meeting, Maureen Kelly from UNC-Chapel Hill Hospitals School of Nursing explained how to successfully transition a pediatric patient with IBD to adult care.
In a Keynote session at the 2018 AIBD Meeting, Dr James Lindsay highlighted the use of biologics and biosimilars, as well as its challenges, for the treatment of ulcerative colitis and Crohn disease.
At the 2018 AIBD Meeting, Dr Corey Siegel discussed the importance of provider engagement and how to eliminate common mistakes in the treatment of acute severe ulcerative colitis.